The apoptosis inhibitor ARC alleviates the ER stress response to promote β-cell survival

Wendy M McKimpson1, Jeremy Weinberger, Lech Czerski

  • 1Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.

Diabetes
|August 31, 2012
PubMed

Insights

Apoptosis repressor with caspase recruitment domain (ARC) protects pancreatic beta cells from death. ARC inhibits apoptosis by suppressing the endoplasmic reticulum stress response, offering a new target for type 2 diabetes therapies.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Molecular Biology

Background:

  • Type 2 diabetes is characterized by insulin resistance and beta-cell failure, leading to insufficient insulin secretion.
  • Beta-cell loss through apoptosis is a critical factor in the progression of type 2 diabetes.
  • Apoptosis repressor with caspase recruitment domain (ARC) is a known inhibitor of apoptosis in various cell types, including neurons and myocytes.

Purpose of the Study:

  • To investigate the role of ARC in pancreatic beta-cell survival and apoptosis.
  • To determine if ARC expression is altered in beta-cells and if it influences apoptosis induced by common beta-cell stressors.
  • To elucidate the mechanism by which ARC might protect beta-cells from apoptosis.

Main Methods:

  • Utilized genetic gain- and loss-of-function approaches in beta-cells.
  • Examined ARC protein abundance in mouse and human pancreatic beta-cells.
  • Assessed the impact of ARC on apoptosis induced by endoplasmic reticulum (ER) stressors (tunicamycin, thapsigargin) and palmitate.
  • Investigated ARC's effect on the ER stress response pathway, including PERK, IRE1α, and CHOP.
  • Studied the interaction between ARC and CHOP in palmitate-induced apoptosis.

Main Results:

  • ARC protein is highly abundant in pancreatic beta-cells (>99.5% in mouse, 73% in human).
  • ARC significantly inhibits beta-cell apoptosis induced by ER stressors and palmitate.
  • ARC suppresses the ER stress response pathway, acting downstream of PERK and IRE1α to reduce CHOP induction.
  • Depletion of ARC exacerbates palmitate-induced beta-cell apoptosis, an effect rescued by CHOP deletion.

Conclusions:

  • ARC is a previously unrecognized inhibitor of apoptosis in pancreatic beta-cells.
  • ARC protects beta-cells by suppressing the ER stress response, specifically CHOP induction.
  • Targeting ARC may represent a novel therapeutic strategy for preserving beta-cell function in type 2 diabetes.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...